ClinicalTrials.Veeva

Menu

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Completed

Conditions

Pregnancy, High Risk
Acquired Immunodeficiency Syndrome
HIV Seropositivity

Treatments

Other: Anti HIV Seropositive Pregnant Women

Study type

Observational

Funder types

Other

Identifiers

NCT03777371
HIVinPregnancies

Details and patient eligibility

About

HIV virus is an etiologic agent of ( AIDS ) immunodeficiency syndrome . It is known that the estimated rate of transfer from mother to baby is 25% to 45%, pregnancy rate is 5-10%, pregnancy rate is 15-20% and in lactation period is 5-10%. Risk factors; maternal viral load, breastfeeding, vaginal birth, and prematurity. Although there is a high rate of false positivity in prenatal screening in our country, one of the factors affecting this is the number of pregnancies.

Enrollment

128 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Anti HIV seropositive Pregnant Women

Exclusion criteria

  • Anti HIV seronegative Pregnant Women

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems